CPT code 92229 covers point-of-care retinal imaging for one or both eyes that uses autonomous (machine) analysis and includes the reporting of findings. The code represents a growing class of diagnostic services that apply artificial intelligence at the point of care to detect and monitor retinal disease, and it has implications for clinical workflow, access to diagnostic screening, and payer coverage policies nationwide. Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, payer coverage considerations, common modifiers, and clinical context for use. The publication also summarizes typical sites of service, the service type, and outlines what benchmarks and policy updates are relevant for stakeholders involved in ophthalmology, optometry, primary care, and ambulatory diagnostics. Data not available in the input for associated taxonomies, specific ICD-10 diagnoses, related codes, and detailed payer policy language is noted where applicable.